Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Orexigen(R) Therapeutics Announces Fourth Quarter and Year Ended December 31, 2009 Financial Results
Date:3/9/2010
SOURCE Orexigen Therapeutics, Inc.
Back to topRELATED LINKS
http://www.orexigen.com
'/>"/>
| SOURCE Orexigen Therapeutics, Inc. Copyright©2010 PR Newswire. All rights reserved |
Related medicine technology :
1. Orexigen(R) Initiates Second Phase IIb Empatic(TM) Trial on Schedule
2. Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R)
3. Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
4. Orexigen(R) Therapeutics Schedules July 20, 2009 Teleconference and Webcast Discussion of Contrave(R) Phase 3 Results
5. Orexigen(R) Therapeutics Schedules September 30, 2009 Teleconference and Webcast to Discuss Phase 2b Trial Results From Second Obesity Drug Candidate, Empatic(TM)
6. Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
7. Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results
8. Orexigen(R) Therapeutics to Speak at Lazard Capital Markets Healthcare Conference
9. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635
10. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
11. Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Post Your Comments:
(Date:5/23/2013)... , May 23, 2013 Net Medical Xpress ... telemedicine market, announced today the company has signed a ... staffing company based in Huntsville, AL ... specializes in the staffing and recruitment of telemedicine physicians. ... of the final agreement, which is expected by June ...
(Date:5/23/2013)... May 23, 2013 CAS Medical Systems, Inc. (NASDAQ: ... non-invasive patient monitoring, today announced that Thomas M. ... at the 2 nd Annual Marcum MicroCap Conference on ... New York City . The ... the Estate 10 room and will be available via a ...
(Date:5/23/2013)... NEW YORK , May 23, 2013 Intercept ... clinical stage biopharmaceutical company focused on the development and ... liver diseases, such as primary biliary cirrhosis, today announced ... and Chief Executive Officer, will present at the Deutsche ... Boston on Wednesday, May 29, 2013 ...
Breaking Medicine Technology:Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 2Net Medical Xpress Announces Acquisition of Telemedicine Staffing Company 3CASMED to Present at the 2nd Annual Marcum MicroCap Conference 2... Calif., Sept. 23 Preclinical data of a ... blood pressure) was presented Tuesday, September 21st, at ... Washington, DC, by Christopher D. Owens, MD, MSc, ... Endovascular Surgery, University of California, San Francisco. The ...
... that a new market research report is available ... Surgical Devices: Technologies and Global Markets ... THIS REPORT CONTAINS A focus on ... devices and total disc replacement (TDR) are becoming the ...
Cached Medicine Technology:Promising New Therapy for Drug-Resistant Hypertension Presented at Interventional Cardiology Meeting in Washington, D.C. 2Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 2Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 3Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 4Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 5Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 6Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 7Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 8Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 9Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 10Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 11Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 12Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 13Reportlinker Adds Spinal Surgical Devices: Technologies and Global Markets 14(Date:5/23/2013)... its destruction inside a cell, a cancer-promoting growth ... the development of tumor-suppressing microRNAs (miRNAs) before it,s ... at Nature . , Under conditions of ... growth factor receptor (EGFR) gums up the cell,s ... at The University of Texas MD Anderson Cancer ...
(Date:5/23/2013)... drug about to be tested in a clinical trial ... treatment for Alzheimer,s disease has failed to work with ... patients, according to results of a study by University ... of neuroscience affiliated with the Evelyn F. and William ... emphasized the importance of verifying promising research results before ...
(Date:5/23/2013)... -- Mayo Clinic researchers have used next generation genomic ... prostate cancer tumors have similar genetic origins, which may ... today in the journal Cancer Research . , ... using next generation sequencing in adjacent Gleason patterns in ... changes in pathology," says ,John Cheville, M.D., Mayo Clinic ...
(Date:5/23/2013)... "triple negative" carries a poor prognosis, with limited treatment ... cancer cells the way it,s supposed to. New research ... respond to chemotherapy, and identifies a mechanism to rectify ... Li, PhD, and his team at Western,s Schulich School ... Numb functions to promote the death of cancer cells ...
(Date:5/23/2013)... The Rottenstein Law Group LLP, a ... the Tylenol Lawsuit Information Center at http://www.rotlaw.com/tylenol , ... those who are considering filing lawsuits. , The ... severe liver damage, according to a 2009 report from ... “safety communication,” the FDA warned consumers against using more ...
Breaking Medicine News(10 mins):Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 2Health News:When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs 3Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 2Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 3Health News:Mayo Clinic genomic analysis lends insight to prostate cancer 2Health News:Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center 2[0] When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs[0] Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study[0] Mayo Clinic genomic analysis lends insight to prostate cancer[0] Research identifies a way to make cancer cells more responsive to chemotherapy[0] Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center
... could slow prostate cancer , , WEDNESDAY, April 29 (HealthDay ... citrus flavor, might help ward off painful calcium deposits ... which is known to inhibit calcium formation, according to ... presented Sunday at the American Urological Association annual meeting, ...
... over next 20 years, report warns , , WEDNESDAY, April 29 ... in the number of new cancers over the next two ... of minorities, a new report predicts. , Rates of ... among the population generally and by 67 percent among people ...
... /PRNewswire/ -- The Senate Finance Committee is ... that the Senate Finance Committee has shown a commitment ... health care system and is considering adopting many of ... We also appreciate that the Committee is considering several ...
... Speaker Nancy Pelosi spoke on the House floor this morning ... year 2010. The resolution passed the House by a vote of ... Senate later today. It does not require the signature of the ... it is indeed an honor to call Mr. Spratt a colleague. ...
... The Jonsson Cancer Center Foundation at UCLA ... Cure , May 1, 2009 at the Beverly Wilshire ... Dana Walden will receive the Gil Nickel Humanitarian Award, ... Barbara Fairchild, Editor-in-Chief, Bon Appetit Magazine; Jon Holman, President, ...
... 29 It is with great privilege that Avery ... Krieger, M.D., F.A.C.S. as Chief Clinical Liaison.Dr. Krieger,s expertise ... was Chief of Neurological Surgery at the University ... Based on that initial experience, Dr. Krieger went on ...
Cached Medicine News:Health News:Some Diet Sodas May Ward Off Kidney Stones 2Health News:Some Diet Sodas May Ward Off Kidney Stones 3Health News:Minorities to Bear Brunt of Rise in U.S. Cancer Cases 2Health News:Minorities to Bear Brunt of Rise in U.S. Cancer Cases 3Health News:Pelosi: Budget is a Blueprint for the Future 2Health News:Pelosi: Budget is a Blueprint for the Future 3Health News:Pelosi: Budget is a Blueprint for the Future 4Health News:UCLA's Jonsson Cancer Center Foundation 'Taste for a Cure' Honors Twentieth Century Fox Television Chairmen Dana Walden and Gary Newman 2Health News:Dr. Abbott J. Krieger Joins Avery Biomedical Devices, Inc. as Chief Clinical Liaison 2Some Diet Sodas May Ward Off Kidney StonesMinorities to Bear Brunt of Rise in U.S. Cancer CasesWellPoint Statement on Senate Finance Committee Health Reform Options PaperPelosi: Budget is a Blueprint for the FutureUCLA's Jonsson Cancer Center Foundation 'Taste for a Cure' Honors Twentieth Century Fox Television Chairmen Dana Walden and Gary NewmanDr. Abbott J. Krieger Joins Avery Biomedical Devices, Inc. as Chief Clinical Liaison
...
Medtronic neurosurgery external drainage and monitoring (EDM) products meet a variety of needs for CSF drainage and monitoring....
Lumbar External Drainage System (LED) with Touhy needle is indicated for temporary access to the Lumbar Subarachnoid region as a means of draining cerebral spinal fluid (CSF) in order to reduce incre...
Monitorr ICP external CSF drainage system with self-contained ICP setting....
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |